Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 16-May-24 5:02 PM View:  | BioSante Pharmaceuticals, I... (ANIP) | 14-May-24 | Private Sale | 16,669 | $66.10 | $1,101,820.00 | (4%) 394.17K to 377.5K | |
| 25-Mar-24 4:09 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 23-Mar-24 | Payment of Exercise | 17,455 | $69.58 | $1,214,520.00 | (4%) 411.63K to 394.17K | |
| 08-Mar-24 7:25 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 08-Mar-24 | Sale | 16,292 | $67.13 | $1,093,680.00 | (4%) 427.92K to 411.63K | |
| 08-Mar-24 7:25 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 07-Mar-24 | Payment of Exercise | 17,060 | $66.71 | $1,138,070.00 | (4%) 444.98K to 427.92K | |
| 08-Mar-24 7:25 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 06-Mar-24 | Private Sale | 28,965 | $65.52 | $1,897,790.00 | (6%) 473.95K to 444.98K | |
| 01-Mar-24 5:06 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 29-Feb-24 | Payment of Exercise | 10,014 | $67.67 | $677,647.00 | (2%) 483.96K to 473.95K | |
| 16-Feb-24 4:56 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 14-Feb-24 | Grant | 134,216 | -- | -- | 38% 349.74K to 483.96K | |
| 11-Sep-23 6:23 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 08-Sep-23 | Payment of Exercise | 3,646 | $61.94 | $225,833.00 | (1%) 353.39K to 349.74K | |
| 15-Aug-23 8:39 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 15-Aug-23 | Option Exercise | 11,616 | $29.00 | $336,864.00 | 3% 353.39K to 365.01K | |
| 15-Aug-23 8:39 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 15-Aug-23 | Sale | 11,616 | $61.13 | $710,086.00 | (3%) 365.01K to 353.39K | |
| 15-Aug-23 8:39 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 11-Aug-23 | Private Option Sale | 11,616 | $57.75 | $670,824.00 | (3%) 410.06K to 398.44K | |
| 15-Aug-23 8:39 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 11-Aug-23 | Sale | 45,050 | $57.75 | $2,601,640.00 | (11%) 398.44K to 353.39K | |
| 27-Mar-23 8:01 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 23-Mar-23 | Payment of Exercise | 17,455 | $37.82 | $660,148.00 | (7%) 268.3K to 250.84K | |
| 09-Mar-23 6:44 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 07-Mar-23 | Payment of Exercise | 13,662 | $44.23 | $604,270.00 | (5%) 281.96K to 268.3K | 2% |
| 04-Apr-23 8:10 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 28-Feb-23 | Grant | 159,216 | -- | -- | 63% 250.84K to 410.06K | |
| 12-Sep-22 8:15 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 08-Sep-22 | Payment of Exercise | 3,646 | $37.61 | $137,126.00 | (1%) 285.6K to 281.96K | |
| 29-Apr-22 6:32 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 27-Apr-22 | Grant | 33,352 | -- | -- | 13% 252.25K to 285.6K | |
| 28-Mar-22 8:46 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 24-Mar-22 | Grant | 100,055 | -- | -- | 66% 152.2K to 252.25K | |
| 25-Mar-22 8:52 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 23-Mar-22 | Payment of Exercise | 17,454 | $27.03 | $471,782.00 | (10%) 169.65K to 152.2K | |
| 23-Mar-22 9:05 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 21-Mar-22 | Private Purchase | 7,224 | $27.69 | $199,997.00 | 4% 162.43K to 169.65K | |
| 10-Sep-21 5:36 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 08-Sep-21 | Payment of Exercise | 2,577 | $28.20 | $72,671.40 | (2%) 165.0K to 162.43K | (8%) |
| 25-Mar-21 4:43 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 23-Mar-21 | Grant | 136,495 | -- | -- | 479% 28.51K to 165.0K | |
| 10-Sep-20 6:18 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 08-Sep-20 | Grant | 28,508 | -- | -- | 100% 0 to 28.51K |